Forget the Headlines: Novo Nordisk's (Nvo) 4.6% Dividend Yield Is the Real Story for Patient Investors The Motley Fool 1d
Pharmaceutical giant Novo Nordisk to cut 215 more Plainsboro jobs after earlier round of layoffs News 12 New Jersey 1d
Novo’s Wegovy significantly reduces BMI in children aged six to 12 Clinical Trials Arena 3d Ozempic Tirzepatide Obesity All sources
Grandad sues Ozempic maker Novo Nordisk claiming weight loss jab left him partially blind The Mirror 11:35 Fri, 13 Nov Novo Nordisk Ozempic Article paywall All sources
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China AsiaOne 09:17 Fri, 13 Nov Eli Lilly Diet and Fitness China All sources
Expert warns of battleground over global access to newer GLP-1 drugs for obesity STAT 5d Obesity Global Health All sources